Clinical Study of Generic and Brand Bupropion in Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 25, 2014

Primary Completion Date

August 14, 2016

Study Completion Date

August 14, 2016

Conditions
Major Depressive Disorder
Interventions
DRUG

Bupropion XL 300

"Subjects will be studied in 4 phases for a total of approximately 28 weeks:~Phase 1: an approximately 4-week lead-in phase during which participants remain on their existing bupropion product Phases 2 - 4: randomized cross-over phases of approximately 6 weeks on each of the four bupropion study drugs (brand and 3 generics)."

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT02209597 - Clinical Study of Generic and Brand Bupropion in Depression | Biotech Hunter | Biotech Hunter